SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-24-129981
Filing Date
2024-05-03
Accepted
2024-05-03 08:00:27
Documents
4
Period of Report
2024-06-26

Document Format Files

Seq Description Document Type Size
1 DEF 14A d503506ddef14a.htm DEF 14A 324335
2 GRAPHIC g503506g35g35.jpg GRAPHIC 215227
3 GRAPHIC g503506g36g36.jpg GRAPHIC 100173
4 GRAPHIC g503506g81k15.jpg GRAPHIC 55398
  Complete submission text file 0001193125-24-129981.txt   821482
Mailing Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE SUITE 700 CAMBRIDGE MA 02139 617-586-3100
Foghorn Therapeutics Inc. (Filer) CIK: 0001822462 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39634 | Film No.: 24910827
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)